Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Nrc Health Q3 2026 Results: Net Income $4.7M, Up 14.1% YoY

NRC Health reported revenue of $38.4 million for the third quarter of 2026, an 11% increase over the prior year, though nine-month operating income fell from $17.9 million to $11.2 million due to higher selling, general, and administrative expenses. The company maintained its quarterly dividend of $0.16 per share while significantly increasing treasury stock repurchases, contributing to a total shareholders' deficit of $9.1 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue38.434.6
Profit before tax7.46.3
Net income4.74.1
EPS (diluted, $ a share)$0.21$0.18

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+14.1%
Revenue, year on year+11.0%
Operating margin23.2%
Source

10-Q filed with the SEC, NASDAQ: NRC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Nrc Health: key numbers

Share price
$25.89Close, Nov 17
Market cap
$549M
Shares outstanding
21.22MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological ResearchSIC 8731

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Nrc Health

All →
4:03 PM ET 8-K
Financial Results

Nrc Health Financial Results

NRC Health reported third-quarter 2026 revenue of $38.4 million, an 11% increase year-over-year, driven by the successful launch of a large customer and multi-year renewals. The company also declared a quarterly cash dividend of $0.16 per share payable in January 2027.

Term
Q3 2026

“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion. Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base. As our expanding contract base converts into revenue, the operating leverage inherent in our model will translate into greater profitability and free cash flow over time, reinforcing our confidence in NRC Health’s ability to create long-term shareholder value.”

Trent Green, CEO of NRC Health
10:29 AM ET 8-K
Leadership Change

Nrc Health Leadership Change

NRC Health has appointed its current CEO, Trent Green, to the additional role of interim principal financial officer effective October 14, 2026. No compensation changes were made in connection with this appointment, and Mr. Green has served as the company's CEO since June 2025.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.